WO2014144983A2 - System and method for reconstructing cardiac activation information - Google Patents
System and method for reconstructing cardiac activation information Download PDFInfo
- Publication number
- WO2014144983A2 WO2014144983A2 PCT/US2014/029616 US2014029616W WO2014144983A2 WO 2014144983 A2 WO2014144983 A2 WO 2014144983A2 US 2014029616 W US2014029616 W US 2014029616W WO 2014144983 A2 WO2014144983 A2 WO 2014144983A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- point
- change
- cardiac signal
- analysis
- signal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0033—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room
- A61B5/0036—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room including treatment, e.g., using an implantable medical device, ablating, ventilating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02405—Determining heart rate variability
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/0245—Detecting, measuring or recording pulse rate or heart rate by using sensing means generating electric signals, i.e. ECG signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/0255—Recording instruments specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/25—Bioelectric electrodes therefor
- A61B5/279—Bioelectric electrodes therefor specially adapted for particular uses
- A61B5/28—Bioelectric electrodes therefor specially adapted for particular uses for electrocardiography [ECG]
- A61B5/283—Invasive
- A61B5/287—Holders for multiple electrodes, e.g. electrode catheters for electrophysiological study [EPS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/339—Displays specially adapted therefor
- A61B5/341—Vectorcardiography [VCG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
- A61B5/361—Detecting fibrillation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
- A61B5/363—Detecting tachycardia or bradycardia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
- A61B5/364—Detecting abnormal ECG interval, e.g. extrasystoles, ectopic heartbeats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
- A61B5/366—Detecting abnormal QRS complex, e.g. widening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6852—Catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
- A61B5/7207—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise induced by motion artifacts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
- A61B5/7217—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise originating from a therapeutic or surgical apparatus, e.g. from a pacemaker
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7239—Details of waveform analysis using differentiation including higher order derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7246—Details of waveform analysis using correlation, e.g. template matching or determination of similarity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7278—Artificial waveform generation or derivation, e.g. synthesising signals from measured signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7282—Event detection, e.g. detecting unique waveforms indicative of a medical condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/04—Arrangements of multiple sensors of the same type
- A61B2562/046—Arrangements of multiple sensors of the same type in a matrix array
Definitions
- Certain systems and methods are known for treating simple heart rhythm disorders.
- a simple heart rhythm disorder e.g., atrial tachycardia
- consistent activation onset patterns from beat to beat can generally be traced back to an earliest location, which can be ablated to mitigate and in some cases to eliminate the disorder.
- ablation of the cause of a heart rhythm disorder is challenging and experienced practitioners often require hours to ablate simple rhythm disorders with consistent beat-to-beat activation patterns, such as atrial tachycardia.
- activation onset time is a time point at which activation commences in a cell or tissue, as opposed to other time points during activation.
- activation is a process whereby a cell commences its operation from a quiescent (diastolic) state to an active (electrical) state.
- a method of reconstructing biological activation information includes processing an analysis cardiac signal and a reference cardiac signal to determine whether there is a first point of change in a first selected-order derivative of the analysis cardiac signal with respect to a first selected- order derivative of the reference cardiac signal above a first threshold.
- The also includes processing the analysis cardiac signal and the reference cardiac signal to determine whether there is a second point of change in a second selected-order derivative of the analysis cardiac signal with respect to a second selected- order derivative of the reference cardiac signal above a second threshold.
- FIG. 5 illustrates example comparison pairs of signals from the sensors array illustrated in FIG. 4;
- FIG. 6 is an illustration of an example signal pair comparison of analysis signal
- FIG. 8 is an illustration of a further example signal pair comparison of analysis signal (SIGl) and reference signal (SIG2) utilizing a composite signal;
- FIG. 12 is a block diagram of an illustrative embodiment of a general computer system.
- FIG. 1 illustrates an example cardiac activation reconstruction system 100.
- the example system 100 is configured to detect and reconstruct cardiac activation information collected/detected from a patient's heart in connection with a heart rhythm disorder.
- the heart includes a right atrium 122, left atrium 124, right ventricle 126 and left ventricle 128.
- the example system 100 includes a catheter 102, signal processing device 1 14, computing device 116 and analysis database 118.
- the catheter 102 is configured to detect cardiac activation information in the heart and to transmit the detected cardiac activation information to the signal processing device 114, either via a wireless or wired connection.
- the catheter includes a plurality of probes/sensors 104-112, which can be inserted into the heart through the patient's blood vessels.
- one or more of the sensors 104-112 are not inserted into the patient' s heart.
- some sensors may detect cardiac activation via the patient's surface (e.g., electrocardiogram) or remotely without contact with the patient (e.g., magnetocardiogram).
- some sensors may also derive cardiac activation information from cardiac motion of a non-electrical sensing device (e.g., echocardiogram). In various embodiments or aspects, these sensors can be used separately or in different
- the computing device 116 is configured to receive (or access) cardiac signals from the signal processing device 114 and further configured to analyze or process the cardiac signals in accordance with methods, functions or logic disclosed herein to reconstruct cardiac activation information in the cardiac signals such that it is possible to locate a cause of the heart rhythm disorder and to eliminate the cause.
- the computing device 116 can process a first cardiac signal and a second cardiac signal from the received cardiac signals to determine whether there is a point of change in a derivative of the first cardiac signal with respect to a derivative of the second cardiac signal above a threshold. The computing device 116 can then assign an activation onset time in the first signal at the point of change to define cardiac activation indicating a beat in the first signal if it is determined that the point of change is above the threshold.
- the computing device 116 can iteratively select pairs of cardiac signals from the received cardiac signals, each pair having a first cardiac signal and second cardiac signal.
- the computing device 116 can process and assign for each of the pairs in order to define multiple cardiac activations indicating beats for the first cardiac signal in each of the pairs.
- the computing device 116 is configured to perform processing and assigning to define multiple cardiac activations indicating beats in the first cardiac signal.
- the computing device 116 can then reconstruct a cardiac activation pattern based on assigned activation onset times of cardiac activations from the received cardiac signals to indicate a source of a rhythm disorder.
- the computing device 116 can also display the reconstructed cardiac activation pattern to facilitate treatment of cardiac tissue at the source to suppress, lessen or eliminate the cardiac rhythm disorder.
- the analysis database 118 is configured to support or aid in the analysis of the signals by the computing device 116.
- the analysis database 118 can store a catalog of reference signals and associated activations to enable the computing device 116 to determine an activation onset associated with a signal being considered (e.g., when point of change is below threshold during a time window), as will be described in greater detail herein.
- FIG. 2 illustrates an example simple electrogram signal 200 of a heart rhythm disorder from a sensor positioned at a sensor location in the heart 120.
- sensor 104 of catheter 102 can be positioned at a sensor location in the right atrium 122, as shown in FIG. 1.
- the heart rhythm disorder can be a complex rhythm disorder AF, VF and polymorphic VT, or another heart rhythm disorder.
- the example signal 200 is for a time period between about 300 ms and about 900 ms.
- the signal 200 is expected to have four (4) local activation onsets 202-208, e.g., those activation onsets that originate at or near (locally to) the sensor location in the heart 120 of sensor 104.
- cycle length between activation onsets of about 100 ms to about 300 ms can be expected for AF
- cycle length between activation onsets of about 180 ms to about 240 ms can be expected for complex ventricular arrhythmias.
- cycle length 210 of about 100 ms to about 300 is expected between activation onset 202 and activation onset 204.
- the activation onsets 202-208 are generally identifiable as having a small degree of baseline wander superposed in the local signal with few far-field artifacts that could be mistaken as local activity.
- Local activity in this example can be characterized by an activation onset with a sharp inflection point and high slope, followed by a period of gentle, low-deviation slope representing repolarization, typically lasting between about 100 ms and 250 ms.
- an example far-field deflection 212 is illustrated between location activation onset 206 and local activation onset 208, e.g., an activation onset that originates at a location in the heart 120 that is different than the sensor location associated with the sensor 104.
- the heart 120 at the sensor location associated with sensor 104 cannot physiologically activate again after activation onset 206 in a shorter cycle than about 100 ms to about 300 ms because local tissue must undergo repolarization.
- the deflection 212 cannot be local to the sensor location associated with the sensor 104 when the deflection 212 is also significantly present in signals collected by neighbor sensors in multiple directions to sensor 104.
- FIG. 3 illustrates an example complex electrogram signal 300 of a heart rhythm disorder from a sensor positioned at a sensor location in the heart 120.
- sensor 106 of catheter 102 can be positioned at a sensor location in the right atrium 122, as shown in FIG. 1.
- the heart rhythm disorder can be a complex rhythm disorder AF, VF and polymorphic VT, or another heart rhythm disorder.
- FIG. 4 illustrates an example array of sensors 400 of catheter 102 and an example selection of signals from the sensors to reconstruct cardiac activation information (e.g., activation onsets).
- the array 400 includes fifteen (15) example sensors for simplicity and clarity of the description. It is to be understood that the array 400 can include fewer or more sensors to as may be determined to cover different portions of the heart 120. In some embodiments or aspects, the array 400 can include 160 or more sensors.
- the sensors of the array 400 are shown in example spatial arrangement with respect to the right atrium 122 of the heart 120.
- the array 400 can be spatially arranged in other chambers of the heart, e.g., left atrium, right ventricle, left ventricle, or for combinations of chambers including the endocardial or epicardial surfaces.
- the spatial arrangement of electrodes in the array 400 is shown to be uniform and planar for simplicity and clarity of the description.
- the heart 120 is not a uniform or planar structure.
- the spatial arrangement of electrodes in the array 400 can be varied with respect to the shape of the heart 120 to improve detection of electric activity in the heart 120.
- Pairs of sensors (signals of sensors) in the array 400 are iteratively selected for processing as will be described in greater detail herein in order to reconstruct cardiac activation information (activation onsets) of the heart 120 in the right atrium 122, or another chamber in which the array 400 may be disposed.
- FIG. 5 illustrates example comparison pairs of signals from the sensors of the array 400 illustrated in FIG. 4.
- Neighbor signals can include not only those signals that are immediately adjacent to the analysis signal but also those signals not adjacent to the analysis signal. Spatially separating the paired sensors can have the effect of spatially extending the area over which deflections are considered to be local activity. Local activity is therefore approximately defined by the separation of the paired sensors.
- selected analysis signal (1) is processed against adjacent signals (2)-(5) and also against a non-adjacent signal (6).
- selected analysis signal (1) is processed against adjacent signals (2)-(5) and also against a non-adjacent signals (6) and (7). While closest neighbor signals are preferred, neighbor signals in various spatial orientations with respect to the analysis signal can be used.
- each analysis signal there could be a plurality of reference signals (e.g., four
- the final activation onset for the analysis signal can be determined based on an average of the possible activation onsets from those pairs of signals in which a plurality of the possible activation onsets are within a predetermined time interval of each other (e.g., ⁇ 5 ms). The time interval used can be chosen to be lower or higher.
- the final activation can also be determined by performing a "center-of-mass" calculation weighted by the significance value of each of the possible activation onsets in the majority, or by analysis of a predominant direction of activation onsets relative to sensor locations.
- each signal from a sensor of array 400 can represent multiple successive analysis intervals (e.g., activation cycles) as illustrated in FIG. 2, each of which can have an activation onset as determined based on the same time interval of multiple reference signals (neighboring sensors of array 400).
- FIG. 6 is an illustration of an example signal pair comparison 600 of example analysis signal (SIG1) and example reference signal (SIG2).
- the signals can be from comparison pair 402 (or comparison pair 404) illustrated in FIG. 4, or from any comparison pair illustrated in FIG. 5. It is noted that the signals are illustrative and occur during the same analysis interval. As noted herein, the signals can have multiple successive analysis intervals (e.g., activation cycles), as illustrated in FIG. 2.
- the signals are processed at one or more successive time points (e.g., every millisecond, two milliseconds, or other time points) to determine whether there is a point of change in a derivative of the analysis signal with respect to a derivative of the reference signal above a threshold.
- the point of change can be determined from one or more of slope, amplitude, timing and shape for the first cardiac signal and the second cardiac signal. It is noted that in some embodiments or aspects, processing of some time points can be omitted (e.g., every other time point or two of three time points). While the slope can be determined by a first-order derivative and/or a second-order derivative for each of the time points in the signals, this example shows calculations using the first-order derivative.
- a root mean squared is determined for each of the signals. For example, RMS 1 and RMS2 are determined by taking a root mean squared of the derivatives (first-order and/or second-order) for the entire signal of each of the signals (e.g., all activation cycles). RMS can be used to normalize the amplitude of the signals with respect to one another, such that amplitudes (e.g., voltage) of the deflections in the signals do not affect the processing of the signals as described below.
- the slopes of the lines can be determined by first-order and/or second order derivatives More specifically, the determined lines represent slopes of the signals at the selected time point for the same time increment (e.g., 10 ms). A significance value ( ⁇ ) is determined with respect to the slopes.
- the significance threshold indicates that there is a potentially significant point of change (based on slopes) for the time point in the signals under consideration, e.g., that the derivatives diverge sufficiently from each other.
- the low significance value indicates that the deflection in SIG1 is far-field and not sufficiently local to a sensor location from which the signal originated, e.g., a sensor shown in FIG. 4. Accordingly, there is no potentially significant point of change in the example signal pair comparison 600.
- significance value ( ⁇ ) calculations are shown and described with reference to the slopes using first-order derivatives, it should be noted that second-order derivatives can be computed instead of, or in addition to, the first-order derivatives in a similar fashion.
- a second significance value ( ⁇ ) calculated based on slopes using-second order derivatives can then be compared to a second significance threshold defined for the second-order derivative. Significance thresholds can be different for the first and second calculated significance values ( ⁇ ).
- the signals can have multiple successive analysis intervals (e.g., activation cycles), as illustrated in FIG. 2.
- each analysis interval it is possible to have zero, one or more potentially significant points of change as described above.
- the time point under consideration and the potentially significant point(s) of change can be recorded, such as in database 118.
- FIG. 7 is an illustration of an example signal pair comparison 700 of example analysis signal (SIG1) and example reference signal (SIG2).
- the signals can be from comparison pair 402 (or comparison pair 404) illustrated in FIG. 4, or from any comparison pair illustrated in FIG. 5.
- the signals are illustrative and occur during the same analysis interval.
- the signals can have multiple successive analysis intervals (e.g., activation cycles), as illustrated in FIG. 2.
- the signals are processed at one or more successive time points to determine whether there is a point of change in a derivative of the analysis signal with respect to a derivative of the reference signal above a threshold.
- processing of some time points can be omitted (e.g., every other time point or two of three time points).
- a first derivative (or second derivative) is determined for each of the time points in the signals.
- a root mean squared is further determined for each of the signals.
- a time point (same time point or about the same time point) is successively selected from each of the signals (SIG1, SIG2) for consideration and processing. For each time point under consideration, a time increment 702, 704 (e.g., 10 ms) in each signal starting at that time point can be considered.
- a line which is pinned to the point under consideration in each signal and which provides the best fit to the time points in the time increment of each signal is determined.
- the determined lines represent the slopes (e.g., volts/per second) of the signals for the selected time point. More specifically, the determined lines represent the slopes at the selected time point for the same time increment.
- a significance value ( ⁇ ) is determined with respect to the slopes.
- a noise level can be defined as fraction of the significance threshold (first, second or third) or can be defined programmatically in various ways.
- noise level can be one-tenth (0.025) of the significance threshold (0.25).
- a different fraction level can be selected.
- the noise level can be defined as a Gaussian standard deviation of a plurality of significance values.
- the significance threshold e.g., 0.25
- the noise level is higher than the noise level that can be associated with the analysis signal and reference signal in the example signal pair comparison 700. Accordingly, a point of change at or below noise level can be associated with one or more signals from other regions of a heart, respiratory system, gastrointestinal tract, neurological system as well as electronic interference.
- significance value ( ⁇ ) calculations are shown and described with reference to the slopes using first-order derivatives, it should be noted that second-order derivatives can be computed instead of, or in addition to, the first-order derivatives in a similar fashion.
- a second significance value ( ⁇ ) calculated based on slopes using-second order derivatives can then be compared to a second significance threshold defined for the second-order derivative. Significance thresholds can be different for the first and second calculated
- the signals can have multiple successive analysis intervals (e.g., activation cycles) and in each analysis interval, it is possible to have zero, one or more potentially significant points of change as described above.
- the time point under consideration and the potentially significant point(s) of change can be recorded, such as in database 118.
- the signals are processed at one or more successive time points to determine whether there is a point of change in a derivative of the analysis signal with respect to a derivative of the reference signal above a threshold.
- processing of some time points can be omitted (e.g., every other time point or two of three time points).
- a first derivative zero order derivative or second derivative
- a root mean squared is further determined for each of the signals.
- a time point (same time point or about the same time point) is successively selected from each of the signals (SIG1, SIG2) for consideration and processing.
- a time increment 802, 804 (e.g., 10 ms) in each signal starting at that time point can be used.
- a line which is pinned to the point under consideration in each signal and which provides the best fit to the time points in the time increment of each signal is determined.
- the determined lines represent the slopes (e.g., volts/per second) of the signals for the selected time point. More specifically, the determined lines represent the slopes of the signals at the selected time point for same time increment.
- significance value ( ⁇ ) calculations are shown and described with reference to the slopes using first-order derivatives, it should be noted that second-order derivatives can be computed instead of, or in addition to, the first-order derivatives in a similar fashion.
- a second significance value ( ⁇ ) calculated based on slopes using-second order derivatives can then be compared to a second significance threshold defined for the second-order derivative. Significance thresholds can be different for the first and second calculated significance values ( ⁇ ).
- the significance value ( ⁇ ) can be determined with respect to a composite signal.
- the composite signal can represent a bipolar signal (COMP) of constituent unipolar signals (SIGl, SIG2).
- the composite signal COMP can also be computed by adding signals SIGl and SIG2.
- the signals in the signal pair comparison 800 are illustrative and occur during the same analysis interval. As noted herein, the signals can have multiple successive analysis intervals (e.g., activation cycles), as illustrated in FIG. 2.
- the signals SIGl, SIG2 are processed at one or more successive time points with respect to the composite signal COMP to determine whether there is a point of change in a derivative of the analysis signal with respect to a derivative of the reference signal above a threshold.
- a first derivative (or second derivative) is determined for each of the time points in the signals, SIG1, SIG2, COMP.
- a time point (same time point or about the same time point) is successively selected from each of the signals (SIG1, SIG2, COMP) for consideration and processing.
- a time increment 802, 804, 806 e.g., 10 ms in each signal starting at that time point can be considered.
- a line which is pinned to the point under consideration in each signal and which provides the best fit to the time points in the time increment of each signal is determined.
- the determined lines represent the slopes (e.g., volts/per second) of the signals for the selected time point. More specifically, the determined lines represent the slopes of the signals at the selected time point for the same time increment.
- a significance value ( ⁇ ) is determined with respect to the slopes.
- the significance value ( ⁇ ) can be determined by a ratio taking an absolute value of the second slope and subtracting an absolute value of the composite slope, and dividing by a logarithm of a result of an absolute value the first slope subtracting an absolute value of the composite slope.
- Significance values can be computed for all points under consideration.
- a significance threshold can be determined to be an average of the computed significance values ( ⁇ ) plus a standard deviation. Thereafter, only those significance values ( ⁇ ) that are above the significance threshold can be considered to be potentially significant points of change for the comparison pair 800.
- the determined significance threshold can be 10. It is noted that the significance value(s) that is above the significance threshold generally extends substantially above the significance threshold. For example, a significance value ( ⁇ ) — having the largest ratio— can therefore be selected.
- significance value ( ⁇ ) calculations using the composite signal are shown and described with reference to the slopes using first-order derivatives, it should be noted that second-order derivatives can be computed instead of, or in addition to, the first-order derivatives in a similar fashion.
- a third significance value ( ⁇ ) calculated based on slopes using-second order derivatives can then be compared to a third significance threshold defined for the second-order derivative. Significance thresholds can be different for the first, second and third calculated significance values ( ⁇ ).
- the signals can have multiple successive analysis intervals (e.g., activation cycles) and in each analysis interval, it is possible to have zero, one or more potentially significant points of change as described above.
- the time point under consideration and the potentially significant point(s) of change can be recorded, such as in database 118.
- a first signal is selected.
- a second signal is selected. Selection of the analysis signal and the reference signal can be performed as described in greater detail with reference to FIGS. 4 and 5. In some embodiments or aspects, a root mean squared (RMS) can be determined for the first signal and for the second signal.
- RMS root mean squared
- a time interval over which the first signal and the second signal are to be compared is selected. The time interval can be selected to be an activation cycle (e.g., 100 ms to 300 ms) as described in FIG. 2. In some embodiments or aspects, the time interval can be determined by a dominant frequency analysis or other analysis of the average cycle length of the first (analysis) signal.
- a default time interval of 200 ms can be used if the time interval cannot be determined computationally.
- the time interval can be selected manually, computationally by a different analysis method, from a database that catalogs such time intervals for patients of a certain age, gender and type of heart rhythm disorder, or defaulted to a value between about 100 ms and about 300 ms.
- a time point is selected for consideration in the selected time interval.
- the same or about the same time point is selected for consideration in each signal (e.g., first signal and second signal).
- derivatives are calculated for a time increment (e.g., 10 ms) extending from the point of consideration in each signal. It is noted that first-order derivatives and/or second-order derivatives are calculated in each signal. In those embodiments or aspects that use a composite signal, a derivative is also calculated for a time increment (e.g., 10 ms) extending from a time point of consideration in the composite signal. Similarly, in those embodiments or aspects using the composite signal, first-order derivatives and/or second-order derivatives are calculated in each signal.
- the time point of consideration in the composite signal is the same or about the same as in the other signals (e.g., first signal and second signal).
- the point of change for the first-order derivatives can be determined with reference to a first threshold, while the point of change for second-order derivatives can be determined with reference to a second threshold, and the point of change for composite signals can be determined with reference to a third threshold.
- the first threshold can be 0.25 (or another value) as described with reference to FIGS. 6-8 and the second threshold can be the same or a different value, while in those embodiments or aspects that use a composite signal, a third threshold can be computed as an average value plus a standard deviation of all points of change as described with reference to FIG. 8.
- the method 900 continues at operation 920 where the significant point(s) of change is recorded (selected) as a possible activation onset(s) for the time interval under consideration in the first (analysis) signal. If however, it is determined that there is no point of change above the threshold (no significant point of change), the method 900 continues at operation 924 where the first signal is compared over the time interval to a catalog of reference signals. For example, the catalog of reference signals for heart rhythm disorders can be maintained in database 118. At operation 926, a determination is made as to whether there is a match to a reference signal in the database. The comparison can be based on at least one characteristic of the first signal to at least one characteristic of the reference signal, such as shape, slope, amplitude, frequency and/or timing. Other characteristics can be used together with or instead of the enumerated characteristics.
- the threshold e.g., first threshold, second threshold, third threshold
- the method 900 continues at operation 920 where the significant point(s) of change is recorded (selected) as a
- the method 900 continues at operation 922.
- the method 900 continues at operation 928 where the point(s) of change in the time interval under consideration is recorded (selected), which would correspond to activation onset(s) in the reference signal that was matched.
- determination of the next time interval can be extended to consider significant points of change from all second (reference) signals for the same time interval under consideration. However, if it is determined that all time intervals have been processed at operation 922, the method 900 continues at operation 930.
- an activation onset(s) is assigned in the first signal at the point(s) of change to define cardiac activation(s) indicating a beat(s) in the first signal if it is determined (at operation 918) that the point(s) of change is above the threshold (e.g., first threshold, second threshold, third threshold). Contention among points of change based on the different thresholds (first, second and third thresholds) can be resolved as set forth below in greater detail.
- an activation onset(s) can be assigned in the first signal at the point(s) of change to define cardiac activation(s) indicating a beat(s) in the first signal based on a matched reference signal (at operation 928).
- activation onsets are assigned to the time intervals of the first signal based on the recorded (or significant) point(s) of change of the first signal with reference to the second signal(s). That is, an activation onset is assigned to each time interval in the first (analysis) signal based possible activation onset(s) associated with the significant point(s) of change in the same time interval of the second (reference) signal(s).
- the activation onset for the time interval of the first (analysis) signal can be determined based on an average of the activation onsets with reference to the second (reference) signals.
- the activation onset for the time interval of the first signal can be determined based on an average of activation onsets with reference to those second signals in which a majority of activation onsets are within a predetermined time interval of each other (e.g., ⁇ 5 ms).
- the activation onset for the time interval can be determined based on an average of activation onsets with reference to those second signals in which a plurality of activation onsets are within a predetermined time interval of each other (e.g., ⁇ 5 ms).
- the assigned onset can be recorded for each interval in the first (analysis) signal such as in database 118.
- signals collected from the heart 120 have been reconstructed with cardiac activation information (activation onsets) such that a cause of the heart rhythm disorder can be determined. More specifically, unipolar electrograms or monophasic action potentials (MAPs) can be mapped to the reconstructed activation onsets of the signals to show unipolar or MAP sequences or representations for the signals. An activation map or pattern can be constructed from these unipolar voltage or MAP voltage representations of the signals to locate the cause of the heart rhythm disorder. An example MAP representation and example activation map are illustrated in FIG. 11. [00101] FIG.
- point of change 1012 in SIG1 that is above threshold 1010 is assigned as the activation onset 1004 for the time interval 1002 in SIG1 based on the first derivative.
- point of change 1014 in SIG1 that is above threshold 1010 is assigned as the activation onset 1004 for the time interval 1002 in SIG1 based on the second derivative.
- Subsequent time intervals are selected and activation onsets are assigned as described herein with reference to FIGS. 1-9 until the analysis signal (SIG1) is processed.
- FIG. 11 is an illustration of an example mapping 1 100 of processed signals in accordance with FIGS. 1-10.
- Raw signal 1100 represents a signal that is processed to assign activation onsets (vertical lines) as described herein.
- a composite signal 1102 is shown, which results from the raw (analysis) signal 1100 and another (reference) signal (not shown).
- a monophasic action potential (MAP) voltage representation is generated from for each processed signal 1100.
- Multiple signals are processed as described herein and MAPs generated based on the processed signals.
- the electrical activity of all MAPs is mapped in a sequence of example activation mappings 1106 to show activation onsets 1108, 1110, 1112 and 1114 at each time interval, respectively.
- These mappings can be displayed by computing device 116. Although only four mapping are shown for illustrative purposes, there can be fewer or greater number of mappings 1106 based on the time intervals represented in the signals.
- mappings 1106 e.g., activation onsets
- the electrical activity indicates a rotational activation pattern of activation onsets (rotor) in the heart rhythm disorder.
- a rotational activation pattern of activation onsets at least a portion of the area of the heart 120 indicated by the rotational activation pattern indicated by the arrows in FIG. 11 can be treated to eliminate the cause of the heart rhythm disorder, and therefore the heart rhythm disorder itself.
- Such treatment may be delivered by ablation using various energy sources (including but not limited to radiofrequency, cryoenergy, microwave, and ultrasound), gene therapy, stem cell therapy, pacing stimulation, drug or other therapy.
- the MAP representation and activation map are examples to illustrate a rotational activation pattern. Other activation patterns can result from different example signals collected by the sensors from the heart 120.
- FIG. 12 is a block diagram of an illustrative embodiment of a general computer system 1200.
- the computer system 1200 can be the signal processing device 114 and the computing device 116 of FIG. 1.
- the computer system 1200 can include a set of instructions that can be executed to cause the computer system 1200 to perform any one or more of the methods or computer based functions disclosed herein.
- the computer system 1200, or any portion thereof, may operate as a standalone device or may be connected, e.g., using a network or other connection, to other computer systems or peripheral devices.
- the computer system 1200 may be operatively connected to signal processing device 114 and analysis database 118.
- the computer system 1200 may also be implemented as or incorporated into various devices, such as a personal computer (PC), a tablet PC, a personal digital assistant (PDA), a mobile device, a palmtop computer, a laptop computer, a desktop computer, a communications device, a control system, a web appliance, or any other machine capable of executing a set of instructions (sequentially or otherwise) that specify actions to be taken by that machine.
- PC personal computer
- PDA personal digital assistant
- mobile device a palmtop computer
- laptop computer a laptop computer
- desktop computer a communications device
- control system a web appliance
- the computer system 1200 may include a processor
- CPU central processing unit
- GPU graphics-processing unit
- the computer system 1200 may include a main memory 1204 and a static memory 1206 that can communicate with each other via a bus 1226.
- the computer system 1200 may further include a video display unit 1210, such as a liquid crystal display (LCD), an organic light emitting diode (OLED), a flat panel display, a solid state display, or a cathode ray tube (CRT).
- the computer system 1200 may include an input device 1212, such as a keyboard, and a cursor control device 1214, such as a mouse.
- the computer system 1200 can also include a disk drive unit 1216, a signal generation device 1222, such as a speaker or remote control, and a network interface device 1208.
- the disk drive unit In a particular embodiment or aspect, as depicted in FIG. 12, the disk drive unit
- the 1216 may include a computer-readable medium 1218 in which one or more sets of instructions 1220, e.g., software, can be embedded. Further, the instructions 1220 may embody one or more of the methods or logic as described herein. In a particular embodiment or aspect, the instructions 1220 may reside completely, or at least partially, within the main memory 1204, the static memory 1206, and/or within the processor 1202 during execution by the computer system 1200. The main memory 1204 and the processor 1202 also may include computer-readable media.
- dedicated hardware implementations such as application specific integrated circuits, programmable logic arrays and other hardware devices, can be constructed to implement one or more of the methods described herein.
- Apps that may include the apparatus and systems of various embodiments or aspects can broadly include a variety of electronic and computer systems.
- One or more embodiments or aspects described herein may implement functions using two or more specific interconnected hardware modules or devices with related control and data signals that can be communicated between and through the modules, or as portions of an application-specific integrated circuit. Accordingly, the present system encompasses software, firmware, and hardware
- the methods described herein may be implemented by software programs tangibly embodied in a processor-readable medium and may be executed by a processor. Further, in an exemplary, non-limited embodiment or aspect, implementations can include distributed processing, component/object distributed processing, and parallel processing. Alternatively, virtual computer system processing can be constructed to implement one or more of the methods or functionality as described herein.
- a computer-readable medium includes instructions
- the 1220 or receives and executes instructions 1220 responsive to a propagated signal, so that a device connected to a network 1224 can communicate voice, video or data over the network 1224. Further, the instructions 1220 may be transmitted or received over the network 1224 via the network interface device 1208.
- inventive subject matter may be referred to herein, individually and/or collectively, by the term "invention" merely for convenience and without intending to voluntarily limit the scope of this application to any single invention or inventive concept if more than one is in fact disclosed.
- inventive subject matter may be referred to herein, individually and/or collectively, by the term "invention" merely for convenience and without intending to voluntarily limit the scope of this application to any single invention or inventive concept if more than one is in fact disclosed.
- inventive subject matter merely for convenience and without intending to voluntarily limit the scope of this application to any single invention or inventive concept if more than one is in fact disclosed.
Abstract
Description
Claims
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201480010563.7A CN105142509B (en) | 2013-03-15 | 2014-03-14 | System and method for rebuilding heart excitement information |
KR1020157028905A KR20150141965A (en) | 2013-03-15 | 2014-03-14 | System and method for reconstructing cardiac activation information |
MX2015011697A MX2015011697A (en) | 2013-03-15 | 2014-03-14 | System and method for reconstructing cardiac activation information. |
JP2016503166A JP6386024B2 (en) | 2013-03-15 | 2014-03-14 | System and method for reconstructing cardiac activation information |
BR112015022401A BR112015022401A2 (en) | 2013-03-15 | 2014-03-14 | method for reconstructing cardiac activation information, system for reconstructing cardiac activation information, and method for treating a heart rhythm disorder |
RU2015141382A RU2015141382A (en) | 2013-03-15 | 2014-03-14 | System and method for recovering information on excitement of the heart |
AU2014233461A AU2014233461A1 (en) | 2013-03-15 | 2014-03-14 | System and method for reconstructing cardiac activation information |
EP14763969.4A EP2967399A4 (en) | 2013-03-15 | 2014-03-14 | System and method for reconstructing cardiac activation information |
CA2903109A CA2903109A1 (en) | 2013-03-15 | 2014-03-14 | System and method for reconstructing cardiac activation information |
IL241366A IL241366A0 (en) | 2011-05-02 | 2015-09-09 | System and method for reconstructing cardiac activation information |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161481607P | 2011-05-02 | 2011-05-02 | |
US13/217,123 US8165666B1 (en) | 2011-05-02 | 2011-08-24 | System and method for reconstructing cardiac activation information |
US13/438,534 US8594777B2 (en) | 2011-05-02 | 2012-04-03 | System and method for reconstructing cardiac activation information |
US13/840,334 | 2013-03-15 | ||
US13/840,334 US9050006B2 (en) | 2011-05-02 | 2013-03-15 | System and method for reconstructing cardiac activation information |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2014144983A2 true WO2014144983A2 (en) | 2014-09-18 |
WO2014144983A3 WO2014144983A3 (en) | 2014-11-13 |
Family
ID=56291309
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2014/029616 WO2014144983A2 (en) | 2011-05-02 | 2014-03-14 | System and method for reconstructing cardiac activation information |
Country Status (2)
Country | Link |
---|---|
US (4) | US9050006B2 (en) |
WO (1) | WO2014144983A2 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8676303B2 (en) | 2008-05-13 | 2014-03-18 | The Regents Of The University Of California | Methods and systems for treating heart instability |
JP5991706B2 (en) | 2008-10-09 | 2016-09-14 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Method, system, and apparatus for detection, diagnosis, and treatment of biorhythm disorders |
US9392948B2 (en) | 2011-12-09 | 2016-07-19 | The Regents Of The University Of California | System and method of identifying sources for biological rhythms |
US9332915B2 (en) | 2013-03-15 | 2016-05-10 | The Regents Of The University Of California | System and method to identify sources associated with biological rhythm disorders |
US10434319B2 (en) | 2009-10-09 | 2019-10-08 | The Regents Of The University Of California | System and method of identifying sources associated with biological rhythm disorders |
US10398326B2 (en) | 2013-03-15 | 2019-09-03 | The Regents Of The University Of California | System and method of identifying sources associated with biological rhythm disorders |
RU2559639C2 (en) | 2010-04-08 | 2015-08-10 | Де Реджентс Оф Де Юниверсити Оф Калифорния | Methods, system and device for detecting, diagnosing and treating biological rhythm disturbance |
EP2705464B1 (en) | 2011-05-02 | 2018-04-18 | Topera, Inc. | System and method for targeting heart rhythm disorders using shaped ablation |
US8165666B1 (en) | 2011-05-02 | 2012-04-24 | Topera, Inc. | System and method for reconstructing cardiac activation information |
US9107600B2 (en) | 2011-05-02 | 2015-08-18 | The Regents Of The University Of California | System and method for reconstructing cardiac activation information |
US9050006B2 (en) | 2011-05-02 | 2015-06-09 | The Regents Of The University Of California | System and method for reconstructing cardiac activation information |
US10076258B2 (en) | 2013-11-01 | 2018-09-18 | Boston Scientific Scimed, Inc. | Cardiac mapping using latency interpolation |
JP2017502766A (en) * | 2014-01-13 | 2017-01-26 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Medical device for mapping heart tissue |
JP2017506572A (en) | 2014-03-07 | 2017-03-09 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Medical device for mapping heart tissue |
WO2015138167A1 (en) | 2014-03-11 | 2015-09-17 | Boston Scientific Scimed, Inc. | Medical devices for mapping cardiac tissue |
WO2017041892A1 (en) | 2015-09-07 | 2017-03-16 | Ablacon Inc. | System for analyzing electrophysiological data and method for analyzing electrophysiological data |
US20220400951A1 (en) * | 2015-09-07 | 2022-12-22 | Ablacon Inc. | Systems, Devices, Components and Methods for Detecting the Locations of Sources of Cardiac Rhythm Disorders in a Patient's Heart Using Improved Electrographic Flow (EGF) Methods |
US11058342B2 (en) * | 2016-08-11 | 2021-07-13 | Biosense Webster (Israel) Ltd. | Classifying ECG signals |
US10383534B2 (en) | 2016-08-11 | 2019-08-20 | Biosense Webster (Israel) Ltd. | Annotation of a wavefront |
US10575744B2 (en) | 2017-02-24 | 2020-03-03 | Medtronic Cryocath Lp | Pericardial balloon mapping |
US11058309B2 (en) | 2017-07-24 | 2021-07-13 | Edwards Lifesciences Corporation | Finger cuff with extended fixed shell to reduce finger movement |
CN107811612A (en) * | 2017-11-30 | 2018-03-20 | 桂林电子科技大学 | A kind of heart rate and respiratory rate data processing method |
CN109350050B (en) * | 2018-11-20 | 2021-08-17 | 锐捷网络股份有限公司 | Heartbeat interval detection method and device |
US11583346B2 (en) | 2021-04-16 | 2023-02-21 | Physcade, Inc. | Personalized heart rhythm therapy |
US11564591B1 (en) | 2021-11-29 | 2023-01-31 | Physcade, Inc. | System and method for diagnosing and treating biological rhythm disorders |
Family Cites Families (163)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4421114A (en) | 1978-10-30 | 1983-12-20 | Berkovits Barouh V | Tachycardia treatment |
US4630204A (en) | 1984-02-21 | 1986-12-16 | Mortara Instrument Inc. | High resolution ECG waveform processor |
US4905708A (en) | 1985-10-31 | 1990-03-06 | Davies David W | Apparatus for recognizing cardiac rhythms |
EP0268708B1 (en) | 1986-11-20 | 1992-10-07 | Davies, David Wyn | Apparatus for recognising rejection of transplanted hearts |
CN1009330B (en) | 1987-03-30 | 1990-08-29 | 创建基立有限公司 | A kind of computer electrical signal detection blood processor |
US4754763A (en) | 1987-06-17 | 1988-07-05 | Noninvasive Technology, Inc. | Noninvasive system and method for testing the integrity of an in vivo bone |
US5121750A (en) | 1990-03-02 | 1992-06-16 | Katims Jefferson J | Apparatus for locating a catheter adjacent to a pacemaker node of the heart |
US5092341A (en) | 1990-06-18 | 1992-03-03 | Del Mar Avionics | Surface ecg frequency analysis system and method based upon spectral turbulence estimation |
US5172699A (en) | 1990-10-19 | 1992-12-22 | Angelase, Inc. | Process of identification of a ventricular tachycardia (VT) active site and an ablation catheter system |
EP0560569B1 (en) | 1992-03-09 | 1998-07-15 | Angeion Corporation | Fibrillation and tachycardia detection |
US5662108A (en) | 1992-09-23 | 1997-09-02 | Endocardial Solutions, Inc. | Electrophysiology mapping system |
CA2144973C (en) | 1992-09-23 | 2010-02-09 | Graydon Ernest Beatty | Endocardial mapping system |
US5687737A (en) | 1992-10-09 | 1997-11-18 | Washington University | Computerized three-dimensional cardiac mapping with interactive visual displays |
SE9203822D0 (en) | 1992-12-18 | 1992-12-18 | Siemens Elema Ab | DEVICE TO ANALYZE THE FUNCTION OF A HEART |
US5385146A (en) | 1993-01-08 | 1995-01-31 | Goldreyer; Bruce N. | Orthogonal sensing for use in clinical electrophysiology |
US6522905B2 (en) | 1993-03-11 | 2003-02-18 | Jawahar M. Desai | Apparatus and method for cardiac ablation |
US5657755A (en) | 1993-03-11 | 1997-08-19 | Desai; Jawahar M. | Apparatus and method for cardiac ablation |
US5433198A (en) | 1993-03-11 | 1995-07-18 | Desai; Jawahar M. | Apparatus and method for cardiac ablation |
WO1994021168A1 (en) | 1993-03-16 | 1994-09-29 | Ep Technologies, Inc. | Cardiac mapping and ablation systems |
IL116699A (en) | 1996-01-08 | 2001-09-13 | Biosense Ltd | Method of constructing cardiac map |
US5738096A (en) | 1993-07-20 | 1998-04-14 | Biosense, Inc. | Cardiac electromechanics |
US5391199A (en) | 1993-07-20 | 1995-02-21 | Biosense, Inc. | Apparatus and method for treating cardiac arrhythmias |
US5439483A (en) | 1993-10-21 | 1995-08-08 | Ventritex, Inc. | Method of quantifying cardiac fibrillation using wavelet transform |
US5487391A (en) | 1994-01-28 | 1996-01-30 | Ep Technologies, Inc. | Systems and methods for deriving and displaying the propagation velocities of electrical events in the heart |
WO1995020344A1 (en) | 1994-01-28 | 1995-08-03 | Ep Technologies, Inc. | System for examining cardiac tissue electrical characteristics |
US5458621A (en) | 1994-03-15 | 1995-10-17 | Incontrol, Inc. | Automatic gain control and method for enabling detection of low and high amplitude depolarization activation waves of the heart and atrial defibrillator utilizing the same |
WO1996025096A1 (en) | 1995-02-17 | 1996-08-22 | Ep Technologies, Inc. | Acquisition of endocardially or epicardially paced electrocardiograms |
US5711305A (en) | 1995-02-17 | 1998-01-27 | Ep Technologies, Inc. | Systems and methods for acquiring endocardially or epicardially paced electrocardiograms |
WO1996025095A1 (en) | 1995-02-17 | 1996-08-22 | Ep Technologies, Inc. | Systems and methods for making time-sequential measurements of biological events |
EP0830091B1 (en) | 1995-04-20 | 2003-10-29 | Jawahar M. Desai | Apparatus for cardiac mapping and ablation |
AU5487696A (en) | 1995-04-20 | 1996-11-07 | Jawahar M. Desai | Apparatus for cardiac ablation |
US5954665A (en) | 1995-06-07 | 1999-09-21 | Biosense, Inc. | Cardiac ablation catheter using correlation measure |
US5718241A (en) | 1995-06-07 | 1998-02-17 | Biosense, Inc. | Apparatus and method for treating cardiac arrhythmias with no discrete target |
US5848972A (en) | 1995-09-15 | 1998-12-15 | Children's Medical Center Corporation | Method for endocardial activation mapping using a multi-electrode catheter |
US5582173A (en) | 1995-09-18 | 1996-12-10 | Siemens Medical Systems, Inc. | System and method for 3-D medical imaging using 2-D scan data |
US5645070A (en) | 1995-09-25 | 1997-07-08 | Ventritex, Inc. | Method and apparatus for determining the origins of cardiac arrhythmias morphology dynamics |
WO1997017893A1 (en) | 1995-11-13 | 1997-05-22 | Heart Rhythm Technologies, Inc. | System and method for analyzing electrogram waveforms |
AU693388B2 (en) | 1995-11-22 | 1998-06-25 | Medtronic, Inc. | System and method for compressing digitized signals in implantable and battery powered devices |
JP3496131B2 (en) | 1996-02-09 | 2004-02-09 | 日本光電工業株式会社 | ECG monitor |
DE19609411C2 (en) | 1996-03-04 | 1999-11-25 | Biotronik Mess & Therapieg | Method and device for storing signals in an implantable medical device |
US5817134A (en) | 1997-02-25 | 1998-10-06 | Greenhut; Saul E. | Apparatus and method for detecting atrial fibrillation by morphological analysis |
US5954661A (en) | 1997-03-31 | 1999-09-21 | Thomas Jefferson University | Tissue characterization and treatment using pacing |
US6112117A (en) | 1997-05-06 | 2000-08-29 | Cardiac Pacemakers, Inc. | Method and apparatus for treating cardiac arrhythmia using electrogram features |
SE9702678D0 (en) | 1997-07-11 | 1997-07-11 | Siemens Elema Ab | Device for mapping electrical activity in the heart |
US6975900B2 (en) | 1997-07-31 | 2005-12-13 | Case Western Reserve University | Systems and methods for determining a surface geometry |
US7016719B2 (en) | 1997-07-31 | 2006-03-21 | Case Western Reserve University | System and methods for noninvasive electrocardiographic imaging (ECGI) using generalized minimum residual (GMRes) |
US5868680A (en) | 1997-09-23 | 1999-02-09 | The Regents Of The University Of California | Quantitative characterization of fibrillatory spatiotemporal organization |
SE9704311D0 (en) | 1997-11-24 | 1997-11-24 | Pacesetter Ab | A cardiac event detecting system for a heart stimulator |
US6106460A (en) | 1998-03-26 | 2000-08-22 | Scimed Life Systems, Inc. | Interface for controlling the display of images of diagnostic or therapeutic instruments in interior body regions and related data |
US7263397B2 (en) | 1998-06-30 | 2007-08-28 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Method and apparatus for catheter navigation and location and mapping in the heart |
US6301496B1 (en) | 1998-07-24 | 2001-10-09 | Biosense, Inc. | Vector mapping of three-dimensionally reconstructed intrabody organs and method of display |
US6208888B1 (en) | 1999-02-03 | 2001-03-27 | Cardiac Pacemakers, Inc. | Voltage sensing system with input impedance balancing for electrocardiogram (ECG) sensing applications |
US6236883B1 (en) | 1999-02-03 | 2001-05-22 | The Trustees Of Columbia University In The City Of New York | Methods and systems for localizing reentrant circuits from electrogram features |
US6308095B1 (en) | 1999-02-12 | 2001-10-23 | Cardiac Pacemakers, Inc. | System and method for arrhythmia discrimination |
US6438409B1 (en) | 1999-03-25 | 2002-08-20 | Medtronic, Inc. | Methods of characterizing ventricular operations and applications thereof |
US6324421B1 (en) | 1999-03-29 | 2001-11-27 | Medtronic, Inc. | Axis shift analysis of electrocardiogram signal parameters especially applicable for multivector analysis by implantable medical devices, and use of same |
US6115628A (en) | 1999-03-29 | 2000-09-05 | Medtronic, Inc. | Method and apparatus for filtering electrocardiogram (ECG) signals to remove bad cycle information and for use of physiologic signals determined from said filtered ECG signals |
ATE349949T1 (en) | 1999-04-05 | 2007-01-15 | Univ California | ENDOMYOCARDIAL SINGLE-PHASE ACTION POTENTIALS FOR EARLY DETECTION OF MYOCARDIAL PATHOLOGY |
US6449503B1 (en) | 1999-07-14 | 2002-09-10 | Cardiac Pacemakers, Inc. | Classification of supraventricular and ventricular cardiac rhythms using cross channel timing algorithm |
JP3213602B2 (en) | 1999-07-27 | 2001-10-02 | 笠貫 宏 | Intracardiac potential analyzer and method |
FI114282B (en) | 1999-11-05 | 2004-09-30 | Polar Electro Oy | Method, Arrangement and Heart Rate Monitor for Heartbeat Detection |
US6892091B1 (en) | 2000-02-18 | 2005-05-10 | Biosense, Inc. | Catheter, method and apparatus for generating an electrical map of a chamber of the heart |
US6725085B2 (en) | 2000-09-22 | 2004-04-20 | Armin Schwartzman | Method and apparatus for characterizing cardiac tissue from local electrograms |
US6684100B1 (en) | 2000-10-31 | 2004-01-27 | Cardiac Pacemakers, Inc. | Curvature based method for selecting features from an electrophysiologic signals for purpose of complex identification and classification |
US7369890B2 (en) | 2000-11-02 | 2008-05-06 | Cardiac Pacemakers, Inc. | Technique for discriminating between coordinated and uncoordinated cardiac rhythms |
US6941166B2 (en) | 2000-11-10 | 2005-09-06 | C.R. Bard, Inc. | Software controlled electrophysiology data management |
US6510339B2 (en) | 2000-12-06 | 2003-01-21 | Cardiac Pacemakers, Inc. | ECG auto-gain control |
US6584345B2 (en) | 2001-03-13 | 2003-06-24 | Biosense, Inc. | Apparatus and method for measuring a plurality of electrical signals from the body of a patient |
US6856830B2 (en) | 2001-07-19 | 2005-02-15 | Bin He | Method and apparatus of three dimension electrocardiographic imaging |
US6847839B2 (en) | 2001-07-30 | 2005-01-25 | The Trustees Of Columbia University In The City Of New York | System and method for determining reentrant ventricular tachycardia isthmus location and shape for catheter ablation |
US6920350B2 (en) | 2001-08-06 | 2005-07-19 | Ge Medical Systems-Information Technologies, Inc. | Method of and apparatus for displaying and analyzing a physiological signal |
US7215993B2 (en) | 2002-08-06 | 2007-05-08 | Cardiac Pacemakers, Inc. | Cardiac rhythm management systems and methods for detecting or validating cardiac beats in the presence of noise |
US6766190B2 (en) | 2001-10-31 | 2004-07-20 | Medtronic, Inc. | Method and apparatus for developing a vectorcardiograph in an implantable medical device |
US6950696B2 (en) | 2001-11-27 | 2005-09-27 | St. Jude Medical Ab | Method and circuit for detecting cardiac rhythm abnormalities by analyzing time differences between unipolar signals from a lead with a multi-electrode tip |
SE0200624D0 (en) | 2002-02-28 | 2002-02-28 | St Jude Medical | Medical device |
US7043292B2 (en) | 2002-06-21 | 2006-05-09 | Tarjan Peter P | Single or multi-mode cardiac activity data collection, processing and display obtained in a non-invasive manner |
US6950702B2 (en) | 2002-07-15 | 2005-09-27 | Cardiac Pacemakers, Inc. | Use of curvature based features for beat detection |
US7123954B2 (en) | 2002-09-19 | 2006-10-17 | Sanjiv Mathur Narayan | Method for classifying and localizing heart arrhythmias |
US7031764B2 (en) | 2002-11-08 | 2006-04-18 | Cardiac Pacemakers, Inc. | Cardiac rhythm management systems and methods using multiple morphology templates for discriminating between rhythms |
US7076288B2 (en) | 2003-01-29 | 2006-07-11 | Vicor Technologies, Inc. | Method and system for detecting and/or predicting biological anomalies |
US6985768B2 (en) | 2003-02-28 | 2006-01-10 | Medtronic, Inc. | Physiological event detection |
US7477932B2 (en) | 2003-05-28 | 2009-01-13 | Cardiac Pacemakers, Inc. | Cardiac waveform template creation, maintenance and use |
US7620446B2 (en) | 2003-07-31 | 2009-11-17 | Medtronic, Inc. | Monitoring P-waves to detect degradation of atrial myocardium |
US7142916B2 (en) | 2003-10-07 | 2006-11-28 | Medtronic, Inc. | Cardiac pacing modality having improved blanking, timing, and therapy delivery methods for extra-systolic stimulation pacing therapy |
US7412287B2 (en) | 2003-12-22 | 2008-08-12 | Cardiac Pacemakers, Inc. | Automatic sensing vector selection for morphology-based capture verification |
WO2005112749A1 (en) | 2004-05-12 | 2005-12-01 | Zoll Medical Corporation | Ecg rhythm advisory method |
US20050288599A1 (en) | 2004-05-17 | 2005-12-29 | C.R. Bard, Inc. | High density atrial fibrillation cycle length (AFCL) detection and mapping system |
US7206630B1 (en) | 2004-06-29 | 2007-04-17 | Cleveland Medical Devices, Inc | Electrode patch and wireless physiological measurement system and method |
US7797036B2 (en) | 2004-11-30 | 2010-09-14 | Cardiac Pacemakers, Inc. | Cardiac activation sequence monitoring for ischemia detection |
US8175702B2 (en) | 2004-11-04 | 2012-05-08 | The Washington University | Method for low-voltage termination of cardiac arrhythmias by effectively unpinning anatomical reentries |
US7328063B2 (en) | 2004-11-30 | 2008-02-05 | Cardiac Pacemakers, Inc. | Method and apparatus for arrhythmia classification using atrial signal mapping |
US7117030B2 (en) | 2004-12-02 | 2006-10-03 | The Research Foundation Of State University Of New York | Method and algorithm for spatially identifying sources of cardiac fibrillation |
WO2006066324A1 (en) | 2004-12-21 | 2006-06-29 | Sydney West Area Health Service | Automated processing of electrophysiological data |
US7430446B2 (en) | 2005-01-20 | 2008-09-30 | Cardiac Pacemakers, Inc. | Methods and apparatuses for cardiac arrhythmia classification using morphology stability |
US7567835B2 (en) | 2005-04-18 | 2009-07-28 | Medtronic, Inc. | Method and apparatus for identifying oversensing using far-field intracardiac electrograms and marker channels |
US20050203502A1 (en) | 2005-04-22 | 2005-09-15 | Boveja Birinder R. | Method and system for monitoring atrial fibrillation ablations with an ablation interface device |
WO2006131851A1 (en) | 2005-06-09 | 2006-12-14 | Koninklijke Philips Electronics, N.V. | Morphograms in different time scales for robust trend analysis in intensive/critical care unit patients |
CN101194271B (en) | 2005-06-09 | 2012-04-04 | 皇家飞利浦电子股份有限公司 | Method and apparatus for distinguishing between clinically significant changes and artifacts in patient physiological information |
US7529578B2 (en) | 2005-07-12 | 2009-05-05 | Cardiac Pacemakers, Inc. | Multi channel approach to capture verification |
US8838215B2 (en) | 2006-03-01 | 2014-09-16 | Angel Medical Systems, Inc. | Systems and methods of medical monitoring according to patient state |
US20070055167A1 (en) | 2005-09-02 | 2007-03-08 | Bullinga John R | System and method for analysis of cardiac arrhythmia using timing and variability of relationships between elctrogram features |
ES2960372T3 (en) | 2005-09-06 | 2024-03-04 | Impulse Dynamics Nv | Device for supplying electrical signals to a heart |
US8229545B2 (en) | 2005-09-15 | 2012-07-24 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for mapping complex fractionated electrogram information |
US7974691B2 (en) | 2005-09-21 | 2011-07-05 | Cardiac Pacemakers, Inc. | Method and apparatus for controlling cardiac resynchronization therapy using cardiac impedance |
US7657307B2 (en) | 2005-10-31 | 2010-02-02 | Medtronic, Inc. | Method of and apparatus for classifying arrhythmias using scatter plot analysis |
US7751882B1 (en) | 2005-12-21 | 2010-07-06 | Pacesetter, Inc. | Method and system for determining lead position for optimized cardiac resynchronization therapy hemodynamics |
US7729753B2 (en) | 2006-03-14 | 2010-06-01 | Cardionet, Inc. | Automated analysis of a cardiac signal based on dynamical characteristics of the cardiac signal |
US7742812B2 (en) | 2006-03-29 | 2010-06-22 | Medtronic, Inc. | Method and apparatus for detecting arrhythmias in a medical device |
US7962202B2 (en) | 2006-03-31 | 2011-06-14 | Medtronic, Inc. | Method and apparatus for verifying a determined cardiac event in a medical device based on detected variation in hemodynamic status |
US7729752B2 (en) | 2006-06-13 | 2010-06-01 | Rhythmia Medical, Inc. | Non-contact cardiac mapping, including resolution map |
US7515954B2 (en) | 2006-06-13 | 2009-04-07 | Rhythmia Medical, Inc. | Non-contact cardiac mapping, including moving catheter and multi-beat integration |
US7505810B2 (en) | 2006-06-13 | 2009-03-17 | Rhythmia Medical, Inc. | Non-contact cardiac mapping, including preprocessing |
EP2745773A3 (en) | 2006-06-13 | 2014-07-02 | Rhythmia Medical, Inc. | Non-contact cardiac mapping, including moving catheter and multi-beat integration |
GB0618522D0 (en) | 2006-09-20 | 2006-11-01 | Imp Innovations Ltd | Atrial fibrillation analysis |
US7890163B2 (en) | 2006-10-19 | 2011-02-15 | Cardiac Pacemakers, Inc. | Method and apparatus for detecting fibrillation using cardiac local impedance |
US7738948B2 (en) | 2006-10-31 | 2010-06-15 | Medtronic, Inc. | Form parameter forecaster for analyzing signals distorted by noise |
US7751873B2 (en) | 2006-11-08 | 2010-07-06 | Biotronik Crm Patent Ag | Wavelet based feature extraction and dimension reduction for the classification of human cardiac electrogram depolarization waveforms |
US7996055B2 (en) | 2006-12-29 | 2011-08-09 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Cardiac navigation system including electrode array for use therewith |
US7907994B2 (en) | 2007-01-11 | 2011-03-15 | Biosense Webster, Inc. | Automated pace-mapping for identification of cardiac arrhythmic conductive pathways and foci |
US7890172B2 (en) | 2007-01-18 | 2011-02-15 | Cardiac Pacemakers, Inc. | Pacing output configuration selection for cardiac resynchronization therapy patients |
US7930020B2 (en) | 2007-04-27 | 2011-04-19 | Medtronic, Inc. | Morphology based arrhythmia detection |
US8095206B2 (en) | 2007-05-01 | 2012-01-10 | Medtronic, Inc. | Method and apparatus for detecting arrhythmias in a medical device |
US8224432B2 (en) | 2007-05-08 | 2012-07-17 | C.R.Bard, Inc. | Rapid 3D mapping using multielectrode position data |
US8588885B2 (en) | 2007-05-09 | 2013-11-19 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Bendable catheter arms having varied flexibility |
US7801594B1 (en) | 2007-10-22 | 2010-09-21 | Pacesetter, Inc. | Morphology discrimination based on inflection point-related information |
US8666483B2 (en) | 2007-10-24 | 2014-03-04 | Siemens Medical Solutions Usa, Inc. | System for cardiac medical condition detection and characterization |
US8396541B2 (en) | 2007-10-24 | 2013-03-12 | Siemens Medical Solutions Usa, Inc. | Signal analysis of cardiac and other patient medical signals |
US20090112199A1 (en) | 2007-10-25 | 2009-04-30 | Siemens Medical Solutions Usa,Inc. | Ep signal mapping-based optical ablation for patient monitoring and medical applications |
US8165676B2 (en) | 2007-12-21 | 2012-04-24 | Medtronic, Inc. | Optical sensor and method for detecting a patient condition |
US8929975B2 (en) | 2008-04-11 | 2015-01-06 | Siemens Medical Solutions Usa, Inc. | System for heart monitoring, characterization and abnormality detection |
US8870785B2 (en) | 2008-05-09 | 2014-10-28 | Koninklijke Philips N.V. | Contactless respiration monitoring of a patient |
US8676303B2 (en) | 2008-05-13 | 2014-03-18 | The Regents Of The University Of California | Methods and systems for treating heart instability |
US7985185B2 (en) | 2008-06-03 | 2011-07-26 | Biotronik Crm Patent Ag | Heart monitoring apparatus |
US8050751B2 (en) | 2008-07-31 | 2011-11-01 | Medtronic, Inc. | Periodic beat detection to detect artifacts in a cardiac electrogram |
CN101640538A (en) | 2008-08-01 | 2010-02-03 | 扬智科技股份有限公司 | Analog-to-digital converter |
JP5991706B2 (en) | 2008-10-09 | 2016-09-14 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Method, system, and apparatus for detection, diagnosis, and treatment of biorhythm disorders |
CN101461711A (en) | 2009-01-12 | 2009-06-24 | 复旦大学 | Shockable rhythm recognition algorithm based on standard deviation of standard slope absolute value |
US8491487B2 (en) | 2009-02-11 | 2013-07-23 | Edwards Lifesciences Corporation | Detection of parameters in cardiac output related waveforms |
US8265741B2 (en) | 2009-02-23 | 2012-09-11 | Biotronik Crm Patent Ag | Technique for determining signal quality in a physiologic sensing system using high frequency sampling |
US20100239627A1 (en) | 2009-03-20 | 2010-09-23 | Wilson Kurt Whitekettle | Quarternary ammonium salts delivery systems |
US8301233B2 (en) | 2009-03-31 | 2012-10-30 | Medtronic, Inc. | Detecting a condition of a patient using a probability-correlation based model |
US8460196B2 (en) | 2009-05-29 | 2013-06-11 | Atlantis Limited Partnership | Method and apparatus for monitoring brain activity |
US10398326B2 (en) | 2013-03-15 | 2019-09-03 | The Regents Of The University Of California | System and method of identifying sources associated with biological rhythm disorders |
US9392948B2 (en) | 2011-12-09 | 2016-07-19 | The Regents Of The University Of California | System and method of identifying sources for biological rhythms |
US9332915B2 (en) | 2013-03-15 | 2016-05-10 | The Regents Of The University Of California | System and method to identify sources associated with biological rhythm disorders |
US8321005B2 (en) | 2009-10-13 | 2012-11-27 | Siemens Medical Solutions Usa, Inc. | System for continuous cardiac pathology detection and characterization |
EP2353644B1 (en) | 2010-02-09 | 2012-07-04 | BIOTRONIK SE & Co. KG | Cardioverter/defibrillator and signal processing device for classifying intracardiac signals |
GB201004743D0 (en) | 2010-03-22 | 2010-05-05 | Univ Leicester | Method and apparatus for evaluating cardiac function |
RU2559639C2 (en) | 2010-04-08 | 2015-08-10 | Де Реджентс Оф Де Юниверсити Оф Калифорния | Methods, system and device for detecting, diagnosing and treating biological rhythm disturbance |
US8442624B2 (en) | 2010-05-12 | 2013-05-14 | Siemens Medical Solutions Usa, Inc. | System for cardiac medical condition detection |
EP2615969B8 (en) | 2010-09-17 | 2017-08-02 | Cardioinsight Technologies, Inc. | System and methods for computing activation maps |
US8340766B2 (en) | 2010-10-07 | 2012-12-25 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Method and system for identifying cardiac arrhythmia driver sites |
US9002442B2 (en) | 2011-01-13 | 2015-04-07 | Rhythmia Medical, Inc. | Beat alignment and selection for cardiac mapping |
US8433398B2 (en) | 2011-03-10 | 2013-04-30 | Siemens Medical Solutions Usa, Inc. | Signal analysis system for heart condition determination |
US8165666B1 (en) | 2011-05-02 | 2012-04-24 | Topera, Inc. | System and method for reconstructing cardiac activation information |
EP2705464B1 (en) | 2011-05-02 | 2018-04-18 | Topera, Inc. | System and method for targeting heart rhythm disorders using shaped ablation |
US9050006B2 (en) * | 2011-05-02 | 2015-06-09 | The Regents Of The University Of California | System and method for reconstructing cardiac activation information |
US9107600B2 (en) | 2011-05-02 | 2015-08-18 | The Regents Of The University Of California | System and method for reconstructing cardiac activation information |
EP2863792B1 (en) | 2012-06-20 | 2021-02-17 | Boston Scientific Scimed, Inc. | Augmented signal vector analysis to suppress global activation during electrophysiology mapping |
US9295399B2 (en) | 2012-06-20 | 2016-03-29 | Intermountain Invention Management, Llc | Atrial fibrillation treatment systems and methods |
US9031642B2 (en) | 2013-02-21 | 2015-05-12 | Medtronic, Inc. | Methods for simultaneous cardiac substrate mapping using spatial correlation maps between neighboring unipolar electrograms |
US8715199B1 (en) | 2013-03-15 | 2014-05-06 | Topera, Inc. | System and method to define a rotational source associated with a biological rhythm disorder |
US9427169B2 (en) | 2013-05-08 | 2016-08-30 | Cardioinsight Technologies, Inc. | Analysis and detection for arrhythmia drivers |
-
2013
- 2013-03-15 US US13/840,334 patent/US9050006B2/en active Active
-
2014
- 2014-03-14 WO PCT/US2014/029616 patent/WO2014144983A2/en active Application Filing
-
2015
- 2015-03-26 US US14/670,300 patent/US9220427B2/en active Active
- 2015-11-17 US US14/944,096 patent/US9668666B2/en active Active
-
2016
- 2016-11-04 US US15/344,230 patent/US9913615B2/en active Active
Non-Patent Citations (1)
Title |
---|
None |
Also Published As
Publication number | Publication date |
---|---|
US9668666B2 (en) | 2017-06-06 |
US20130226016A1 (en) | 2013-08-29 |
US9050006B2 (en) | 2015-06-09 |
US20150196212A1 (en) | 2015-07-16 |
US9220427B2 (en) | 2015-12-29 |
US9913615B2 (en) | 2018-03-13 |
WO2014144983A3 (en) | 2014-11-13 |
US20160278654A1 (en) | 2016-09-29 |
US20170049402A1 (en) | 2017-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9913615B2 (en) | System and method for reconstructing cardiac activation information | |
US10149622B2 (en) | System and method for reconstructing cardiac activation information | |
US10271786B2 (en) | System and method for reconstructing cardiac activation information | |
EP2787880A1 (en) | Method and system for determining regularity associated with biological rhythm disorders | |
EP2967399A2 (en) | System and method for reconstructing cardiac activation information | |
US10368764B2 (en) | System and method to select signal segments for analysis of a biological rhythm disorder | |
WO2016033075A1 (en) | System and method for reconstructing cardiac activation information |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201480010563.7 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14763969 Country of ref document: EP Kind code of ref document: A2 |
|
REEP | Request for entry into the european phase |
Ref document number: 2014763969 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2014763969 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2014233461 Country of ref document: AU Date of ref document: 20140314 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2903109 Country of ref document: CA |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14763969 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2015/011697 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 2016503166 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 241366 Country of ref document: IL |
|
ENP | Entry into the national phase |
Ref document number: 20157028905 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2015141382 Country of ref document: RU Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112015022401 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112015022401 Country of ref document: BR Kind code of ref document: A2 Effective date: 20150910 |